Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $62,377 - $93,636
2,806 New
2,806 $79,000
Q1 2022

May 16, 2022

SELL
$36.25 - $52.02 $25,918 - $37,194
-715 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $28,082 - $42,652
649 Added 983.33%
715 $34,000
Q3 2021

Nov 15, 2021

BUY
$53.61 - $67.5 $3,538 - $4,455
66 New
66 $4,000
Q4 2020

Feb 16, 2021

SELL
$25.66 - $34.55 $10,828 - $14,580
-422 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$22.51 - $30.11 $9,499 - $12,706
422 New
422 $12,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.